WARRANT AGENCY AGREEMENTWarrant Agency Agreement • March 28th, 2017 • Accelerated Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2017 Company Industry JurisdictionTHIS WARRANT AGENCY AGREEMENT (this “Agreement”) is dated [ ], 2017, between Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and VStock Transfer, LLC, acting as warrant agent (the “Warrant Agent”).
ACCELERATED PHARMA, INC. UNDERWRITING AGREEMENTUnderwriting Agreement • March 28th, 2017 • Accelerated Pharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 28th, 2017 Company Industry Jurisdiction
NINTH AMENDMENT, WAIVER, RESTRUCTURING AND CONSENTNinth Amendment, Waiver, Restructuring and Consent • March 28th, 2017 • Accelerated Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2017 Company IndustryThis Ninth Amendment, Waiver, Restructuring and Consent (“Ninth Consent”), is made and entered into effective as of March 27, 2017 (the “Effective Date”), by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.
ContractPurchase Warrant Agreement • March 28th, 2017 • Accelerated Pharma, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledMarch 28th, 2017 Company Industry JurisdictionTHE REGISTERED HOLDER OF THIS PURCHASE WARRANT BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE WARRANT EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE WARRANT AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE WARRANT FOR A PERIOD OF THREE HUNDRED AND SIXTY (360) DAYS FOLLOWING THE EFFECTIVE DATE (DEFINED BELOW) TO ANYONE OTHER THAN (I) RODMAN & RENSHAW, A DIVISION OF H.C. WAINWRIGHT & CO., LLC, OR A REPRESENTATIVE OR A SELECTED DEALER IN CONNECTION WITH THE OFFERING, OR (II) A BONA FIDE OFFICER OR PARTNER OF RODMAN & RENSHAW, A DIVISION OF H.C. WAINWRIGHT & CO., LLC, OR OF ANY SUCH REPRESENTATIVEOR SELECTED DEALER.
EIGHTH AMENDMENT, WAIVER AND CONSENTEighth Amendment, Waiver and Consent • March 28th, 2017 • Accelerated Pharma, Inc. • Pharmaceutical preparations
Contract Type FiledMarch 28th, 2017 Company IndustryThis Eighth Amendment, Waiver and Consent (“Eighth Consent”), is made and entered into effective as of January 30, 2017 (the “Effective Date”), by and among Accelerated Pharma, Inc., a Delaware corporation (the “Company”), and the parties identified on the signature page hereto (each a “Purchaser” and collectively, “Purchasers”). Capitalized terms used but not defined herein will have the meanings assigned to them in the Securities Purchase Agreements and Transaction Documents (as defined below). Capitalized terms defined herein shall be incorporated in the Transaction Documents, as appropriate.